ACADIA Pharmaceuticals Inc. vs Core Scientific Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.55 (market cap $5.07B), while Core Scientific Inc trades at $20.93 (market cap $6.35B). The key difference: Core Scientific Inc is the larger of the two by market cap, and ACADIA Pharmaceuticals Inc. is trading nearer its 52-week high, Core Scientific Inc nearer its low. Which is the better fit depends on your goals.
| ACAD | CORZ | |
|---|---|---|
Market Cap | $5.07B | $6.35B |
Sector | Health | Technology |
52-Week High | $29.41 | $29.16 |
52-Week Low | $20.06 | $13.55 |
Enterprise Value | $4.19B | $8.88B |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.
Read more on CORZ →